High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The interest in the use of human dendritic cells in cancer immunotherapy calls for efficient ex vivo methods of dendritic cell education. To extend the range of methods available, we generated phenotypically characteristic dendritic cells from peripheral blood monocytes incubated with granulocyte-macrophage colony-stimulating factor and interleukin-4 and infected them with an adenovirus containing a humanized version of green fluorescent protein as a marker of gene expression. The levels of expressed protein were high, but they were further increased in combination with cationic liposomes. In comparison to transfection efficiency of the homologous expression plasmid, adenovirus-mediated gene transfer was substantially more efficient. With the aid of liposome-mediated infection, gene transfer into CD83+ dendritic cells was highly effective, resulting in more than 90% of the cells expressing the transgene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, DCs can be transfected to comparable levels as compared with transduction by recombinant viruses, such as poxviruses 22 or adenoviruses, 4 while circumventing the drawbacks of viral vectors.23,24”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804
Cited by
Dendritic Cells in Cancer Immunotherapy
Fong, L., & Engleman, E. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.245 · Cited by 680
Dendritic Cell Vaccines for Cancer Immunotherapy
Timmerman, M., & Levy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.507 · Cited by 485
Van Tendeloo, V. F. I., Ponsaerts, P., Lardon, F., Nijs, G., Lenjou, M., Van Broeckhoven, C., Van Bockstaele, D. R., & Berneman, Z. N. (2001) · Blood · doi:10.1182/blood.v98.1.49 · Cited by 468
Hartman, Z. C., Appledorn, D. M., & Amalfitano, A. (2008) · Virus Research · doi:10.1016/j.virusres.2007.10.005 · Cited by 239
“While Ad induced maturation of DCs was originally a matter of some dispute, the great majority of studies support the view that Ad infection activates DCs of both murine and human lineages (Dietz and Vuk-Pavlovic, 1998; Hirschowitz et al., 2000; Korst et al., 2002; Lyakh et al., 2002; Miller et al., 2003; Varnavski et…”
ResultLentivirally transduced dendritic cells as a tool for cancer immunotherapy
Breckpot, K., Dullaers, M., Bonehill, A., Van Meirvenne, S., Heirman, C., De Greef, C., van der Bruggen, P., & Thielemans, K. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.400 · Cited by 177
Metadata
- Authors
- Dietz, A. B., & Vuk-Pavlovic, S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-01-15
- Volume
- 91
- Issue
- 2
- Pages
- 392-398
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W9574997
- Cited by
- 195
- References
- 1
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells. https://app.cochat.ai/papers/10.1182/blood.v91.2.392
- The paper
- Dietz, A. B., & Vuk-Pavlovic, S. (1998). High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells. Blood. https://doi.org/10.1182/blood.v91.2.392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.